![Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial - ScienceDirect Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109718351969-gr6.jpg)
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial - ScienceDirect
![Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - . | Semantic Scholar Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - . | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b403497b551de0d92e4ed33cfaec207dc27d6d9/2-Figure1-1.png)
Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - . | Semantic Scholar
![PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data | tctmd.com PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data | tctmd.com](https://s3.amazonaws.com/prod.tctmd.com/public/styles/large_slide_teaser/public/2019-09/6168DF11-D147-44E7-862A-9E9361F7B132.png?itok=wY6zrAgZ)
PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data | tctmd.com
![Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2 ... Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2 ...](https://i0.wp.com/thoracickey.com/wp-content/uploads/2016/11/gr1-591.jpg?fit=566%2C387&ssl=1)
Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2 ...
![Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3 ... Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3 ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/a60ab14e-5d35-4309-b181-33927986deae/gr1.jpg)
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3 ...
![Percutaneous Coronary Interventions for All Patients With Complex Coronary Artery Disease: Triple Vessel Disease or Left Main Coronary Artery Disease. Yes? No? Don??t Know? | Revista Española de Cardiología Percutaneous Coronary Interventions for All Patients With Complex Coronary Artery Disease: Triple Vessel Disease or Left Main Coronary Artery Disease. Yes? No? Don??t Know? | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13140253:255v62n07-13140253fig4.jpg?idApp=UINPBA000025)
Percutaneous Coronary Interventions for All Patients With Complex Coronary Artery Disease: Triple Vessel Disease or Left Main Coronary Artery Disease. Yes? No? Don??t Know? | Revista Española de Cardiología
![SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease - Riley - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease - Riley - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/36e025a8-9c43-4258-b2bc-1944b56c6e83/ccd28994-fig-0002-m.jpg)
SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease - Riley - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library
![Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/07c0f8e9-e060-411b-ab32-2428c5a93696/gr1_lrg.jpg)
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet
![Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry | Revista Española de Cardiología Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/thumbnail/S188558571630295X:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w95VGOQIPAvopuSI6ycxV2xQ=)